|Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report|
AJ Rush, MH Trivedi, SR Wisniewski, AA Nierenberg, JW Stewart, ...
American Journal of Psychiatry 163 (11), 1905-1917, 2006
|Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice|
MH Trivedi, AJ Rush, SR Wisniewski, AA Nierenberg, D Warden, L Ritz, ...
American journal of Psychiatry 163 (1), 28-40, 2006
|Medication augmentation after the failure of SSRIs for depression|
MH Trivedi, M Fava, SR Wisniewski, ME Thase, F Quitkin, D Warden, ...
New England Journal of Medicine 354 (12), 1243-1252, 2006
|Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression|
AJ Rush, MH Trivedi, SR Wisniewski, JW Stewart, AA Nierenberg, ...
New England Journal of Medicine 354 (12), 1231-1242, 2006
|Effectiveness of adjunctive antidepressant treatment for bipolar depression|
GS Sachs, AA Nierenberg, JR Calabrese, LB Marangell, SR Wisniewski, ...
New England Journal of Medicine 356 (17), 1711-1722, 2007
|Sequenced treatment alternatives to relieve depression (STAR* D): rationale and design|
AJ Rush, M Fava, SR Wisniewski, PW Lavori, MH Trivedi, HA Sackeim, ...
Controlled clinical trials 25 (1), 119-142, 2004
|Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD)|
RH Perlis, S Miyahara, LB Marangell, SR Wisniewski, M Ostacher, ...
Biological psychiatry 55 (9), 875-881, 2004
|Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)|
RH Perlis, MJ Ostacher, JK Patel, LB Marangell, H Zhang, SR Wisniewski, ...
American Journal of Psychiatry 163 (2), 217-224, 2006
|Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)|
NM Simon, MW Otto, SR Wisniewski, M Fossey, K Sagduyu, E Frank, ...
American Journal of Psychiatry 161 (12), 2222-2229, 2004
|Background and rationale for the sequenced treatment alternatives to relieve depression (STAR* D) study.|
M Fava, AJ Rush, MH Trivedi, AA Nierenberg, ME Thase, HA Sackeim, ...
Psychiatric Clinics of North America, 2003
|Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program|
DJ Miklowitz, MW Otto, E Frank, NA Reilly-Harrington, SR Wisniewski, ...
Archives of general psychiatry 64 (4), 419-426, 2007
|STAR* D: what have we learned?|
American Journal of Psychiatry 164 (2), 201-204, 2007
|Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)|
GS Sachs, ME Thase, MW Otto, M Bauer, D Miklowitz, SR Wisniewski, ...
Biological psychiatry 53 (11), 1028-1042, 2003
|Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial|
AJ Rush, LB Marangell, HA Sackeim, MS George, SK Brannan, SM Davis, ...
Biological psychiatry 58 (5), 347-354, 2005
|The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders|
I Pacchiarotti, DJ Bond, RJ Baldessarini, WA Nolen, H Grunze, RW Licht, ...
American Journal of Psychiatry 170 (11), 1249-1262, 2013
|Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging|
NM Simon, JW Smoller, KL McNamara, RS Maser, AK Zalta, MH Pollack, ...
Biological psychiatry 60 (5), 432-435, 2006
|Residual symptoms in depressed patients who respond acutely to fluoxetine.|
AA Nierenberg, BR Keefe, VC Leslie, JE Alpert, JA Pava, ...
The Journal of clinical psychiatry, 1999
|A Comparison of Lithium and T 3 Augmentation Following Two Failed Medication Treatments for Depression: A STAR*D Report|
AA Nierenberg, M Fava, MH Trivedi, SR Wisniewski, ME Thase, ...
American Journal of Psychiatry 163 (9), 1519-1530, 2006
|Effect of age at onset on the course of major depressive disorder|
S Zisook, I Lesser, JW Stewart, SR Wisniewski, GK Balasubramani, ...
American Journal of Psychiatry 164 (10), 1539-1546, 2007
|Folate, vitamin B₁₂, and homocysteine in major depressive disorder.|
M Fava, JS Borus, JE Alpert, AA Nierenberg, JF Rosenbaum, T Bottiglieri
The American journal of psychiatry, 1997